Sept 8 (Reuters) - Boiron SA BOIR.PA :
* H1 OPERATING LOSS OF EUR 11.0 MILLION VERSUS PROFIT OF EUR
1.5
MILLION YEAR AGO
* H1 REVENUE EUR 190.0 MILLION VERSUS EUR 253.6 MILLION YEAR
AGO
* H1 NET LOSS GROUP SHARE EUR 9.5 MILLION VERSUS LOSS OF EUR
1.0
MILLION YEAR AGO
* THE REORGANISATION OF THE FIFTEEN REMAINING SITES AND THE
CLOSURE OF THE MONTRICHARD SITE ON 31 DECEMBER WILL RESULT IN
THE ADDITIONAL DEPARTURE OF 124 PEOPLE
* IN H2, WE EXPECT SALES OF NON-PROPRIETARY MEDICINES TO
CONTINUE
TO DECLINE COMPARED TO 2020, FOLLOWING THE DELISTING OF
HOMEOPATHIC MEDICINES IN FRANCE
* EXPECT POSITIVE ANNUAL OPERATING RESULT, ALBEIT DOWN ON
2020
* SPECIALTY SALES ARE EXPECTED TO IMPROVE, ALTHOUGH THIS
WILL
DEPEND ON THE DURATION AND EXTENT OF THE HEALTH CRISIS
* CUMULATIVELY FOR THE YEAR, WE ANTICIPATE A SIGNIFICANT
DECLINE
IN TURNOVER
Further company coverage: BOIR.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))